INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2019

Resveratrol supplementation for 4 weeks significantly reduced serum IL6 levels within the intervention group, but showed no differences between groups.

In this randomized clinical trial, 43 patients with type 2 diabetes and chronic periodontitis were randomly allocated to receive resveratrol supplements or placebo for 4 weeks alongside non-surgical periodontal therapy. In the intervention group, the mean serum level of IL6 decreased significantly post-intervention from 2.19 ± 1.09 to 1.58 ± 1.06 (P = 0.039). However, no significant differences were observed between the intervention and control groups post-intervention for IL6, TNFα, TAC, or CAL.

Study type
Randomized clinical trial
Who was studied
43 patients with type 2 diabetes and chronic periodontitis
What was measured
Serum levels of IL6, TNFα, TAC, and clinical attachment loss (CAL)

THE PAPER

Impact of resveratrol supplementation on inflammatory, antioxidant, and periodontal markers in type 2 diabetic patients with chronic periodontitis.

Javid AZ, Hormoznejad R, Yousefimanesh HA, Haghighi-Zadeh MH, Zakerkish M. Diabetes Metab Syndr, 2019.

PubMed 31405706 ↗DOI 10.1016/j.dsx.2019.07.042 ↗

Diabetes & blood sugarOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.